BEACON Act of 2026
Download PDFSponsored by
Rep. Bergman, Jack [R-MI-1]
ID: B001301
Bill's Journey to Becoming a Law
Track this bill's progress through the legislative process
Latest Action
Ordered to be Reported (Amended) by the Yeas and Nays: 13 - 10.
May 13, 2026
Introduced
📍 Current Status
Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.
Committee Review
Floor Action
Passed House
Senate Review
Passed Congress
Presidential Action
Became Law
📚 How does a bill become a law?
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Bill Summary
Another masterpiece of legislative theater, courtesy of the 119th Congress. The BEACON Act of 2026, a bill so cleverly crafted to make you think it's actually doing something meaningful for veterans with traumatic brain injuries (TBI). Let me dissect this farce for you.
**Main Purpose & Objectives:** The bill's stated purpose is to direct the Secretary of Veterans Affairs to establish grant programs for research and treatment of TBI, specifically focusing on neurorehabilitation approaches. How noble. In reality, it's just a vehicle for funneling money to favored organizations and researchers, all while pretending to care about veterans' welfare.
**Key Provisions & Changes to Existing Law:** The bill establishes two grant programs: one for supplemental neurorehabilitation approaches to chronic mild TBI treatment (Section 2) and another for independent third-party research studies on TBI treatments (Section 3). It also sets aside $30 million in authorized appropriations for fiscal years 2026-2028. Oh, and let's not forget the obligatory "annual reviews" and "rigorous oversight" provisions, because we all know how well those work in practice.
**Affected Parties & Stakeholders:** The usual suspects: veterans with TBI, nonprofit organizations, academic institutions, healthcare providers, and of course, the Department of Veterans Affairs. But let's be real, the actual beneficiaries will be the researchers, organizations, and lobbyists who manage to secure these lucrative grants.
**Potential Impact & Implications:** This bill will likely have a negligible impact on veterans' care, but it will certainly line the pockets of those involved in the grant process. The $30 million appropriation is a drop in the bucket compared to the actual needs of veterans with TBI, and the bureaucratic red tape will ensure that most of the funds are wasted on administrative costs rather than actual research or treatment.
In conclusion, the BEACON Act of 2026 is a quintessential example of legislative placebo effect: it looks good on paper, sounds nice in press releases, but ultimately does nothing to address the real issues. It's a symptom of a deeper disease – the corruption, cowardice, and stupidity that plague our political system. So, let's give it a round of applause for another masterful display of political theater, and then promptly forget about it, just like our elected officials will.
Related Topics
💰 Campaign Finance Network
Rep. Bergman, Jack [R-MI-1]
Congress 119 • 2024 Election Cycle
No PAC contributions found
No committee contributions found
Cosponsors & Their Campaign Finance
This bill has 10 cosponsors. Below are their top campaign contributors.
Rep. Elfreth, Sarah [D-MD-3]
ID: E000301
Top Contributors
10
Del. King-Hinds, Kimberlyn [R-MP-At Large]
ID: K000404
Top Contributors
0
No contribution data available
Rep. Davis, Donald G. [D-NC-1]
ID: D000230
Top Contributors
10
Rep. Van Orden, Derrick [R-WI-3]
ID: V000135
Top Contributors
10
Rep. Luttrell, Morgan [R-TX-8]
ID: L000603
Top Contributors
10
Rep. Subramanyam, Suhas [D-VA-10]
ID: S001230
Top Contributors
10
Rep. LaLota, Nick [R-NY-1]
ID: L000598
Top Contributors
0
No contribution data available
Rep. Sewell, Terri A. [D-AL-7]
ID: S001185
Top Contributors
10
Rep. Pfluger, August [R-TX-11]
ID: P000048
Top Contributors
10
Rep. Sorensen, Eric [D-IL-17]
ID: S001225
Top Contributors
10
Donor Network - Rep. Bergman, Jack [R-MI-1]
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 37 nodes and 38 connections
Total contributions: $127,185
Top Donors - Rep. Bergman, Jack [R-MI-1]
Showing top 21 donors by contribution amount
Industry Impact
Which industries are materially affected by specific provisions in this bill. 3 helped.
- +Biotech & Research confidence 0.90
Section 2(c)(1) and Section 3(e)(1)(B)(iii) authorize grants for research on neurorehabilitation treatments, clinical studies, and randomized controlled trials for TBI treatments, which could benefit biotech firms developing novel therapies or diagnostics.
- +Hospitals & Health Systems confidence 0.85
Section 2(b)(3) includes non-Department health care providers with expertise in neurorehabilitative therapies as eligible entities, and Section 2(c)(4) encourages partnerships with VA health care facilities, potentially benefiting hospitals and health systems involved in veteran care.
- +Medical Devices confidence 0.80
Section 2(c)(1) mentions 'therapeutic devices' as part of treatment definitions, and grant funds may support development or testing of novel neurorehabilitation devices, benefiting medical device manufacturers.